radamts13
ItalyDrugs containing this active substance
-
ADZYNMA is used to replenish levels of the ADAMTS13 enzyme, which is absent in people with congenital thrombotic thrombocytopenic purpura (cTTP). This helps to reduce the likelihood of dangerous blood clot formation and to prevent low platelet levels in the blood.
Form: solution for injection, powder and solvent
Active substance Dosage radamts13 - ATC: B01AD13
Manufacturer: TAKEDA MANUFACTURING AUSTRIA AG